Grzegorz Borowski

Grzegorz Borowski

Auto-generated profile, based on publicly available information

Grzegorz Borowski

Independent Public Specialist John Paul II Western Hospital, Grodzisk Mazowiecki, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Journal of Medical Science
Verified
Journal Article
Open access
PDF file
MZMaria Zasadzińska
Maria Zasadzińska
GBGrzegorz Borowski
Grzegorz Borowski
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver disorder globally, and if left untreated, it may progress to liver cirrhosis and even hepatocellular carcinoma. As of 2024, the European Association for the Study of the Liver Guidelines have recommended resmetirom as the only pharmacological treatment for adults with non-cirrhotic MASLD who have significant fibrosis (stage ≥2). However, lifestyle interventions and management of comorbidities, such as type 2 diabetes and obesity, remain the cornerstone of treatment. Glucagon-like peptide-1 receptor agonists, particularly semaglutide, have shown emerging promise in treating MASLD. Notably, the Phase III ESSENCE trial, presented in late 2024, demonstrated semaglutide's potential in improving liver fibrosis, confirmed through histological evaluation, marking a possible breakthrough for MASLD management. This review aims to synthesise current evidence on the efficacy of semaglutide in treating MASLD, highlighting its potential to fill a significant gap in the therapeutic options available for this growing global health concern.

1 January 2023 in Palliative Medicine
Verified
Journal Article
Open access
GBGrzegorz Borowski
Grzegorz Borowski
MZMaria Zasadzińska
Maria Zasadzińska
AMAdam Mróz
Adam Mróz
JZJulia Załęcka
Julia Załęcka
AKAgnieszka Kluczna
Agnieszka Kluczna
Tomasz DzierżanowskiTomasz Dzierżanowski
Tomasz Dzierżanowski
Trigeminal neuralgia is one of the most painful conditions a person can experience. Depending on the aetiology, 3 types of neuralgia can be distinguished: classic, secondary, and idiopathic. It can be a challenge in palliative care, especially in patients with multiple sclerosis, in whom...